A ‘miracle’ new drug from Janssen has been approved in the US
Azure Pharmaceuticals (AZURE) has been granted a patent for a new compound that is designed to reverse the effects of a disease called “malignant neuroendocrine syndrome”.The company said in a press release that it has been working with a clinical trial and regulatory authorities in the USA to finalise the approval.“We are delighted to have…